VIENNA (MedPage Today) -- Researchers in the U.K. are initiating a new trial to bolster what they call a dearth of substantial evidence for the efficacy of metformin, the staple of type 2 diabetes therapy. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment